374Water Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by 374Water Inc. (SCWO) on October 14, 2025, covering events occurring on October 8 and October 9, 2025. The Company, incorporated in Delaware and listed on the Nasdaq Capital Market, focuses on the commercialization of super critical water oxidation technology.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on corporate governance changes and executive compensation arrangements.
Material Changes
- Executive Departures: Christian Gannon stepped down as President, Chief Executive Officer, and Director effective October 8, 2025. Peter Mandel stepped down as General Counsel effective October 8, 2025. Separation details are pending and will be filed in a subsequent Form 8-K/A.
- Executive Appointment: Stephen J. Jones, a current director, was appointed Interim President and Chief Executive Officer effective October 8, 2025. He will lead the company through project deployments and oversee the search for a permanent CEO.
- Compensation Grants:
- Stephen Jones: Granted 4,500,000 stock options with an exercise price of $0.37. Vesting occurs in four 25% tranches over 270 days, subject to continued service. Options vest immediately upon a change of control, hiring of a full-time CEO, or termination other than for cause. Base salary is set at $1.00.
- Other Officers: On October 9, 2025, Russell Kline (CFO) and Brad Meyers (COO) each received 500,000 stock options (total 1,000,000) with an exercise price of $0.60. Vesting is 50% at one year and 50% at two years, subject to continued service. Options vest immediately upon termination unless the officer resigns or is terminated for cause.
Outlook, Risks, and Management Commentary
Management commentary indicates the Board appointed Mr. Jones to lead the company through its "next phase of project deployments and the commercialization of its super critical water oxidation technology." The filing notes that separation details for departing executives are being finalized. No specific financial guidance, risk factors, or contingencies were disclosed in this report.
Investor Verification Checklist
- Verify the finalized separation terms and any severance payments for Christian Gannon and Peter Mandel in the upcoming Form 8-K/A.
- Monitor the timeline for the appointment of a permanent President and CEO, which triggers immediate vesting of Mr. Jones' options.
- Review the Company's cash position to assess its ability to fund project deployments under interim leadership.
- Confirm the impact of the new option grants (5.5 million total shares) on potential dilution for existing shareholders.